Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B
Keywords: CQDSXYOVMHALPF-UHFFFAOYSA-N; OBULGMCFXOTNNK-ZDUSSCGKSA-N; DUGHOSNYUCLBTI-UHFFFAOYSA-N; HCV inhibitor; Replicon; 2-(4-Sulfonamidophenyl)-indole 3-carboxamides; NS4B;